Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
Global HQ
Cambridge, United Kingdom
Countries of investment
    Investment stages
      Industries
        About
        o2h Ventures is a leading investment firm specializing in early-stage biotech and AI opportunities, supporting novel drug discovery, services, tools, and AI technologies to revolutionize healthcare.
        Min check size
        -
        Max check size
        -
        Fund size
        NPS

        Investment Thesis

        Lead investor
        Co Invest
        Number of exits
        Preferred contact method

        Manager's Experience

        With a rich background in venture capital, the fund manager has successfully navigated over 30 investments across technology and healthcare sectors, primarily in the UK and Europe. Their strategic approach emphasizes an operator-first style, enabling them to identify promising early-stage companies. Notable exits have included leading firms in biotechnology and software, showcasing a keen acumen for value creation. Their investment philosophy integrates data-driven insights to refine decision-making and enhance portfolio performance.
        Fund number
        Vintage Year
        Net Internal Rate of Return
        Investment Multiple
        Capital Allocation
        Management Fee
        Carried Interest
        AUM
        Follow-on Investments
        Graduation Rate
        Write-Off Ratio
        Last profile update timestamp